These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8536898)
21. Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Singh P; Gurudu SR; Davidoff S; Sivak MV; Indaram A; Kasmin FE; Nozdak V; Wong RC; Isenberg G; Stark B; Bank S; Chak A Gastrointest Endosc; 2004 Apr; 59(4):499-505. PubMed ID: 15044885 [TBL] [Abstract][Full Text] [Related]
22. Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. Lee TH; Park DH; Park JY; Kim EO; Lee YS; Park JH; Lee SH; Chung IK; Kim HS; Park SH; Kim SJ Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):444-9. PubMed ID: 19007927 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis. Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794 [TBL] [Abstract][Full Text] [Related]
24. Comparative cytotoxicity of low-osmolar nonionic and high-osmolar ionic contrast media to dog gallbladder epithelial cells. Ju YM; Kim MH; Lee SK; Seo DW; Min YI; Kim JY Gastrointest Endosc; 2002 Mar; 55(3):382-6. PubMed ID: 11868013 [TBL] [Abstract][Full Text] [Related]
25. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448 [TBL] [Abstract][Full Text] [Related]
26. Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial. Oh HC; Cheon YK; Cho YD; Do JH Gastrointest Endosc; 2011 Sep; 74(3):556-62. PubMed ID: 21802079 [TBL] [Abstract][Full Text] [Related]
27. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate. O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937 [TBL] [Abstract][Full Text] [Related]
28. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477 [TBL] [Abstract][Full Text] [Related]
29. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study. Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R; Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981 [TBL] [Abstract][Full Text] [Related]
30. Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. Goebel C; Hardt P; Doppl W; Temme H; Hackstein N; Klör HU Eur Radiol; 2000; 10(4):677-80. PubMed ID: 10795554 [TBL] [Abstract][Full Text] [Related]
31. Preventing post-ERCP pancreatitis: where are we? Testoni PA JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013 [TBL] [Abstract][Full Text] [Related]
32. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Lehman GA Gastrointest Endosc; 2007 Mar; 65(3):385-93. PubMed ID: 17321236 [TBL] [Abstract][Full Text] [Related]
33. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Sand J; Nordback I Digestion; 1993; 54(2):105-11. PubMed ID: 8319838 [TBL] [Abstract][Full Text] [Related]
34. Reducing the incidence and severity of post ERCP pancreatitis. Murray WR Scand J Surg; 2005; 94(2):112-6. PubMed ID: 16111092 [TBL] [Abstract][Full Text] [Related]
35. Post-ERCP pancreatitis: association with urographic visualization during ERCP. Roszler MH; Campbell WL Radiology; 1985 Dec; 157(3):595-8. PubMed ID: 4059544 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin injection after biliary sphincterotomy. Gorelick A; Barnett J; Chey W; Anderson M; Elta G Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315 [TBL] [Abstract][Full Text] [Related]
37. Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Hannigan BF; Keeling PW; Slavin B; Thompson RP Gastrointest Endosc; 1985 Apr; 31(2):109-10. PubMed ID: 2581845 [No Abstract] [Full Text] [Related]
38. Early precut is as efficient as pancreatic stent in preventing post-ERCP pancreatitis in high-risk subjects - A randomized study. Zagalsky D; Guidi MA; Curvale C; Lasa J; de Maria J; Ianniccillo H; Hwang HJ; Matano R Rev Esp Enferm Dig; 2016 Sep; 108(9):258-562. PubMed ID: 27604474 [TBL] [Abstract][Full Text] [Related]